With GSK recently coming back to the practice of using HCPs as paid speakers—after a five-year voluntary hiatus that other pharma and device firms did not follow—this article from MM&M (formerly Medical Marketing & Media) details the changes made by those other firms to the paid-speaker process since GSK’s 2013 decision that actually makes the practice more effective and less controversial.
0 comments
Hide comments